Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens

Carriage of commensal bacteria species is associated with the development of natural immunity to meningococcal disease, with lipo-oligosaccharides (LOS) of meningococci being one of the main virulence factors associated with severity of meningococcal disease. Meningococcal reference strains and isol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2004-02, Vol.22 (7), p.898-908
Hauptverfasser: Braun, Jan M, Beuth, Josef, Blackwell, C.Caroline, Giersen, Sonja, Higgins, Paul G, Tzanakaki, Georgina, Unverhau, Heike, Weir, Donald M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 908
container_issue 7
container_start_page 898
container_title Vaccine
container_volume 22
creator Braun, Jan M
Beuth, Josef
Blackwell, C.Caroline
Giersen, Sonja
Higgins, Paul G
Tzanakaki, Georgina
Unverhau, Heike
Weir, Donald M
description Carriage of commensal bacteria species is associated with the development of natural immunity to meningococcal disease, with lipo-oligosaccharides (LOS) of meningococci being one of the main virulence factors associated with severity of meningococcal disease. Meningococcal reference strains and isolates from the commensal species Neisseria lactamica and Moraxella catarrhalis were assessed for the presence of cross-reactive glycoconjugate antigens. Binding of human blood group antibodies of the P and Ii system to meningococcal immunotype reference strains were in accordance with the presence of known LOS carbohydrate structures. Binding studies with meningococcal immunotyping antibodies and blood group phenotyping antibodies to N. lactamica strains from different European countries showed, that a greater number of isolates obtained from native Greek and Scottish adults and children bound anti-meningococcal L(3, 7, 9) immunotyping ( P
doi_str_mv 10.1016/j.vaccine.2003.11.036
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71768916</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X03008338</els_id><sourcerecordid>19253991</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-2c43285ef080f0251ffccc5826c41f55e0f81039ab2090f0893e284ada67f88a3</originalsourceid><addsrcrecordid>eNqFkU2P0zAQhi0EYsvCTwDlAicSZuw4dU4IrfiSFriAxM2aOuOtq3wUO63Yf4-7jbTc9mTZet7xzDxCvESoELB5t6uO5FwYuZIAqkKsQDWPxArNWpVSo3ksViCbuqwRfl-IZyntAEArbJ-KC9RQQ1urldh_55ASx0DFwGMYb8IcupDeFvfvPbmZhuCooLErvk2R_nLfU-Fophi31IdUpC1FLlycUioj50A45ivFzbS97SLNnLNzuOExPRdPPPWJXyznpfj16ePPqy_l9Y_PX68-XJeulnIupauVNJo9GPCQ5_HeOaeNbFyNXmsGbxBUSxsJbSZMq1iamjpq1t4YUpfizbnuPk5_DpxmO4TkTo2PPB2SXeO6MS02D4LYSq3aFjOoz-DdmJG93ccwULy1CPbkxO7s4sSenFhEm53k3Kvlg8Nm4O4-tUjIwOsFoOSo95FGF9J_nFZK3xV6f-Y47-0YONrkAo-OuxDZzbabwgOt_APpHa57</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19253991</pqid></control><display><type>article</type><title>Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Braun, Jan M ; Beuth, Josef ; Blackwell, C.Caroline ; Giersen, Sonja ; Higgins, Paul G ; Tzanakaki, Georgina ; Unverhau, Heike ; Weir, Donald M</creator><creatorcontrib>Braun, Jan M ; Beuth, Josef ; Blackwell, C.Caroline ; Giersen, Sonja ; Higgins, Paul G ; Tzanakaki, Georgina ; Unverhau, Heike ; Weir, Donald M</creatorcontrib><description>Carriage of commensal bacteria species is associated with the development of natural immunity to meningococcal disease, with lipo-oligosaccharides (LOS) of meningococci being one of the main virulence factors associated with severity of meningococcal disease. Meningococcal reference strains and isolates from the commensal species Neisseria lactamica and Moraxella catarrhalis were assessed for the presence of cross-reactive glycoconjugate antigens. Binding of human blood group antibodies of the P and Ii system to meningococcal immunotype reference strains were in accordance with the presence of known LOS carbohydrate structures. Binding studies with meningococcal immunotyping antibodies and blood group phenotyping antibodies to N. lactamica strains from different European countries showed, that a greater number of isolates obtained from native Greek and Scottish adults and children bound anti-meningococcal L(3, 7, 9) immunotyping ( P&lt;0.001), p K ( P=0.035) and paragloboside ( P&lt;0.001) blood group typing antibodies compared to isolates obtained from children of Russian immigrants in Greece. A greater number of M. catarrhalis strains isolated from children in Scotland bound anti-L(3, 7, 9) antibodies (38.2%) compared to strains isolated from adults (22.2%) ( P=0.017). These findings provide evidence that blood group like glycoconjugate antigens found on the commensal species N. lactamica and M. catarrhalis might be involved in the development of natural immunity to meningococcal endotoxins during childhood, and might be exploited as anti-meningococcal vaccine candidates.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2003.11.036</identifier><identifier>PMID: 15040943</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adolescent ; Age Factors ; Antibodies - analysis ; Antibodies, Bacterial - analysis ; Antibody Specificity ; Antigens, Bacterial - immunology ; Applied microbiology ; Bacteriology ; Biological and medical sciences ; Blood Group Antigens - immunology ; Carbohydrates - immunology ; Child ; Cross Reactions ; Cross-reactivity ; Endotoxin ; Enzyme-Linked Immunosorbent Assay ; Europe ; Female ; Fundamental and applied biological sciences. Psychology ; Humans ; Lipopolysaccharides - immunology ; Male ; Meningococcal disease ; Microbiology ; Miscellaneous ; Moraxella (Branhamella) catarrhalis - growth &amp; development ; Moraxella (Branhamella) catarrhalis - immunology ; Moraxella catarrhalis ; Neisseria lactamica ; Neisseria lactamica - growth &amp; development ; Neisseria lactamica - immunology ; Neisseria meningitidis ; Neisseria meningitidis - growth &amp; development ; Neisseria meningitidis - immunology ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><ispartof>Vaccine, 2004-02, Vol.22 (7), p.898-908</ispartof><rights>2003 Elsevier Ltd</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-2c43285ef080f0251ffccc5826c41f55e0f81039ab2090f0893e284ada67f88a3</citedby><cites>FETCH-LOGICAL-c422t-2c43285ef080f0251ffccc5826c41f55e0f81039ab2090f0893e284ada67f88a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.vaccine.2003.11.036$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,777,781,786,787,3537,23911,23912,25121,27905,27906,45976,64366</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15533536$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15040943$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Braun, Jan M</creatorcontrib><creatorcontrib>Beuth, Josef</creatorcontrib><creatorcontrib>Blackwell, C.Caroline</creatorcontrib><creatorcontrib>Giersen, Sonja</creatorcontrib><creatorcontrib>Higgins, Paul G</creatorcontrib><creatorcontrib>Tzanakaki, Georgina</creatorcontrib><creatorcontrib>Unverhau, Heike</creatorcontrib><creatorcontrib>Weir, Donald M</creatorcontrib><title>Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Carriage of commensal bacteria species is associated with the development of natural immunity to meningococcal disease, with lipo-oligosaccharides (LOS) of meningococci being one of the main virulence factors associated with severity of meningococcal disease. Meningococcal reference strains and isolates from the commensal species Neisseria lactamica and Moraxella catarrhalis were assessed for the presence of cross-reactive glycoconjugate antigens. Binding of human blood group antibodies of the P and Ii system to meningococcal immunotype reference strains were in accordance with the presence of known LOS carbohydrate structures. Binding studies with meningococcal immunotyping antibodies and blood group phenotyping antibodies to N. lactamica strains from different European countries showed, that a greater number of isolates obtained from native Greek and Scottish adults and children bound anti-meningococcal L(3, 7, 9) immunotyping ( P&lt;0.001), p K ( P=0.035) and paragloboside ( P&lt;0.001) blood group typing antibodies compared to isolates obtained from children of Russian immigrants in Greece. A greater number of M. catarrhalis strains isolated from children in Scotland bound anti-L(3, 7, 9) antibodies (38.2%) compared to strains isolated from adults (22.2%) ( P=0.017). These findings provide evidence that blood group like glycoconjugate antigens found on the commensal species N. lactamica and M. catarrhalis might be involved in the development of natural immunity to meningococcal endotoxins during childhood, and might be exploited as anti-meningococcal vaccine candidates.</description><subject>Adolescent</subject><subject>Age Factors</subject><subject>Antibodies - analysis</subject><subject>Antibodies, Bacterial - analysis</subject><subject>Antibody Specificity</subject><subject>Antigens, Bacterial - immunology</subject><subject>Applied microbiology</subject><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Blood Group Antigens - immunology</subject><subject>Carbohydrates - immunology</subject><subject>Child</subject><subject>Cross Reactions</subject><subject>Cross-reactivity</subject><subject>Endotoxin</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Europe</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Lipopolysaccharides - immunology</subject><subject>Male</subject><subject>Meningococcal disease</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Moraxella (Branhamella) catarrhalis - growth &amp; development</subject><subject>Moraxella (Branhamella) catarrhalis - immunology</subject><subject>Moraxella catarrhalis</subject><subject>Neisseria lactamica</subject><subject>Neisseria lactamica - growth &amp; development</subject><subject>Neisseria lactamica - immunology</subject><subject>Neisseria meningitidis</subject><subject>Neisseria meningitidis - growth &amp; development</subject><subject>Neisseria meningitidis - immunology</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU2P0zAQhi0EYsvCTwDlAicSZuw4dU4IrfiSFriAxM2aOuOtq3wUO63Yf4-7jbTc9mTZet7xzDxCvESoELB5t6uO5FwYuZIAqkKsQDWPxArNWpVSo3ksViCbuqwRfl-IZyntAEArbJ-KC9RQQ1urldh_55ASx0DFwGMYb8IcupDeFvfvPbmZhuCooLErvk2R_nLfU-Fophi31IdUpC1FLlycUioj50A45ivFzbS97SLNnLNzuOExPRdPPPWJXyznpfj16ePPqy_l9Y_PX68-XJeulnIupauVNJo9GPCQ5_HeOaeNbFyNXmsGbxBUSxsJbSZMq1iamjpq1t4YUpfizbnuPk5_DpxmO4TkTo2PPB2SXeO6MS02D4LYSq3aFjOoz-DdmJG93ccwULy1CPbkxO7s4sSenFhEm53k3Kvlg8Nm4O4-tUjIwOsFoOSo95FGF9J_nFZK3xV6f-Y47-0YONrkAo-OuxDZzbabwgOt_APpHa57</recordid><startdate>20040217</startdate><enddate>20040217</enddate><creator>Braun, Jan M</creator><creator>Beuth, Josef</creator><creator>Blackwell, C.Caroline</creator><creator>Giersen, Sonja</creator><creator>Higgins, Paul G</creator><creator>Tzanakaki, Georgina</creator><creator>Unverhau, Heike</creator><creator>Weir, Donald M</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20040217</creationdate><title>Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens</title><author>Braun, Jan M ; Beuth, Josef ; Blackwell, C.Caroline ; Giersen, Sonja ; Higgins, Paul G ; Tzanakaki, Georgina ; Unverhau, Heike ; Weir, Donald M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-2c43285ef080f0251ffccc5826c41f55e0f81039ab2090f0893e284ada67f88a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Age Factors</topic><topic>Antibodies - analysis</topic><topic>Antibodies, Bacterial - analysis</topic><topic>Antibody Specificity</topic><topic>Antigens, Bacterial - immunology</topic><topic>Applied microbiology</topic><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Blood Group Antigens - immunology</topic><topic>Carbohydrates - immunology</topic><topic>Child</topic><topic>Cross Reactions</topic><topic>Cross-reactivity</topic><topic>Endotoxin</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Europe</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Lipopolysaccharides - immunology</topic><topic>Male</topic><topic>Meningococcal disease</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Moraxella (Branhamella) catarrhalis - growth &amp; development</topic><topic>Moraxella (Branhamella) catarrhalis - immunology</topic><topic>Moraxella catarrhalis</topic><topic>Neisseria lactamica</topic><topic>Neisseria lactamica - growth &amp; development</topic><topic>Neisseria lactamica - immunology</topic><topic>Neisseria meningitidis</topic><topic>Neisseria meningitidis - growth &amp; development</topic><topic>Neisseria meningitidis - immunology</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Braun, Jan M</creatorcontrib><creatorcontrib>Beuth, Josef</creatorcontrib><creatorcontrib>Blackwell, C.Caroline</creatorcontrib><creatorcontrib>Giersen, Sonja</creatorcontrib><creatorcontrib>Higgins, Paul G</creatorcontrib><creatorcontrib>Tzanakaki, Georgina</creatorcontrib><creatorcontrib>Unverhau, Heike</creatorcontrib><creatorcontrib>Weir, Donald M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Braun, Jan M</au><au>Beuth, Josef</au><au>Blackwell, C.Caroline</au><au>Giersen, Sonja</au><au>Higgins, Paul G</au><au>Tzanakaki, Georgina</au><au>Unverhau, Heike</au><au>Weir, Donald M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2004-02-17</date><risdate>2004</risdate><volume>22</volume><issue>7</issue><spage>898</spage><epage>908</epage><pages>898-908</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Carriage of commensal bacteria species is associated with the development of natural immunity to meningococcal disease, with lipo-oligosaccharides (LOS) of meningococci being one of the main virulence factors associated with severity of meningococcal disease. Meningococcal reference strains and isolates from the commensal species Neisseria lactamica and Moraxella catarrhalis were assessed for the presence of cross-reactive glycoconjugate antigens. Binding of human blood group antibodies of the P and Ii system to meningococcal immunotype reference strains were in accordance with the presence of known LOS carbohydrate structures. Binding studies with meningococcal immunotyping antibodies and blood group phenotyping antibodies to N. lactamica strains from different European countries showed, that a greater number of isolates obtained from native Greek and Scottish adults and children bound anti-meningococcal L(3, 7, 9) immunotyping ( P&lt;0.001), p K ( P=0.035) and paragloboside ( P&lt;0.001) blood group typing antibodies compared to isolates obtained from children of Russian immigrants in Greece. A greater number of M. catarrhalis strains isolated from children in Scotland bound anti-L(3, 7, 9) antibodies (38.2%) compared to strains isolated from adults (22.2%) ( P=0.017). These findings provide evidence that blood group like glycoconjugate antigens found on the commensal species N. lactamica and M. catarrhalis might be involved in the development of natural immunity to meningococcal endotoxins during childhood, and might be exploited as anti-meningococcal vaccine candidates.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>15040943</pmid><doi>10.1016/j.vaccine.2003.11.036</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2004-02, Vol.22 (7), p.898-908
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_miscellaneous_71768916
source MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland
subjects Adolescent
Age Factors
Antibodies - analysis
Antibodies, Bacterial - analysis
Antibody Specificity
Antigens, Bacterial - immunology
Applied microbiology
Bacteriology
Biological and medical sciences
Blood Group Antigens - immunology
Carbohydrates - immunology
Child
Cross Reactions
Cross-reactivity
Endotoxin
Enzyme-Linked Immunosorbent Assay
Europe
Female
Fundamental and applied biological sciences. Psychology
Humans
Lipopolysaccharides - immunology
Male
Meningococcal disease
Microbiology
Miscellaneous
Moraxella (Branhamella) catarrhalis - growth & development
Moraxella (Branhamella) catarrhalis - immunology
Moraxella catarrhalis
Neisseria lactamica
Neisseria lactamica - growth & development
Neisseria lactamica - immunology
Neisseria meningitidis
Neisseria meningitidis - growth & development
Neisseria meningitidis - immunology
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
title Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T16%3A27%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neisseria%20meningitidis,%20Neisseria%20lactamica%20and%20Moraxella%20catarrhalis%20share%20cross-reactive%20carbohydrate%20antigens&rft.jtitle=Vaccine&rft.au=Braun,%20Jan%20M&rft.date=2004-02-17&rft.volume=22&rft.issue=7&rft.spage=898&rft.epage=908&rft.pages=898-908&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2003.11.036&rft_dat=%3Cproquest_cross%3E19253991%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19253991&rft_id=info:pmid/15040943&rft_els_id=S0264410X03008338&rfr_iscdi=true